Dr. Robert Hanson is Chair of Dentons’ US Intellectual Property and Technology practice. His practice focuses on Patent counseling and prosecution in biotechnology and the life sciences.
With experience handling biotechnology patents for leading industry, university and non-profit clients, Robert has prosecuted more than four thousand patents to issue in the US and has managed foreign patent portfolios pending in countries around the world. Patents issued from these portfolios cover technologies making up some of the world’s most successful commercial biotechnology products.
Clients turn to Robert for his extensive patent experience, including prosecuting patent applications, invalidity/non-infringement opinions, counseling, patent post-grant proceedings, reissues, European patent oppositions, appeals and all aspects of strategic patent portfolio management and evaluation. With a technical background in biotechnology and genetics, he has successfully advised and represented clients on a variety of technologies including, genetically modified organisms, genetic transformation technology, nucleic acids and DNA vectors, pharmaceuticals, plant breeding and biotechnology, antibodies, biofuels, biological assays, food science, microfluidics, cosmetics, business methods and animal science.
Robert has successfully argued numerous appeals before the US Patent Office Board of Patent Appeals and Interferences. These appeals have substantially changed examination policy in key areas of technology.